Nomura Holdings, Inc. (NMR) Q3 2026 Earnings Call Transcript — Neutral

NMR   Seeking Alpha — January 30, 2026

Nomura Holdings, Inc. (NMR) Q3 2026 Earnings Call Transcript

image for news Nomura Holdings, Inc. (NMR) Q3 2026 Earnings Call Transcript

Novo Nordisk: Momentum Meets Headwinds Before Earnings (Upgrade) — Positive

NVO   Seeking Alpha — January 30, 2026

Novo Nordisk A/S has first-mover advantage in obesity pills and aggressive U.S. marketing, supported by a robust cash position, strengthen its competitive stance in the thriving GLP-1 market. Consensus revenue growth forecasts appear overly pessimistic given NVO's historical double-digit growth and Q4 seasonal strength. Despite positives, technical setup, high valuation (PEG 3.3 vs. 1.8 sector median), and potential profit-taking temper enthusiasm make NVO a Hold.

image for news Novo Nordisk: Momentum Meets Headwinds Before Earnings (Upgrade)

American Express Stock Drops After Mixed Q4 Results — Negative

AXP   Schaeffers Research — January 30, 2026

American Express (NYSE:AXP) stock is slipping today, brushing off the company's better-than-expected fourth-quarter revenue and 16% dividend increase, as investors focus on earnings of $3.04 per share that came in just below estimates.

image for news American Express Stock Drops After Mixed Q4 Results

Mercedes, NVIDIA and Uber Team Up to Build S-Class Robotaxis — Positive

MBGYY  NVDA  UBER   Zacks Investment Research — January 30, 2026

MBGYY is teaming up with NVIDIA and Uber to develop S-Class robotaxis, pairing MB.OS with DRIVE AV Level 4 for a premium autonomous ride.

image for news Mercedes, NVIDIA and Uber Team Up to Build S-Class Robotaxis

Buy, Sell or Hold QCOM Stock? Key Tips Ahead of Q1 Earnings Release — Negative

QCOM   Zacks Investment Research — January 30, 2026

QCOM eyes solid Q1 revenue on AI chip launches, but China tensions and sliding estimates cloud investor sentiment.

image for news Buy, Sell or Hold QCOM Stock? Key Tips Ahead of Q1 Earnings Release

Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and bolster medical supply chains.

image for news Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push

SLINGERLANDS, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG) will host an investor question-and-answer discussion on Monday, February 2, 2026 to provide all stockholders with an opportunity to ask questions regarding the proposals to be voted on at the Company's adjourned Special Meeting of Stockholders on Thursday, February 5, 2026 at 10:00 a.m. ET. At the Special Meeting, Proposals 1 and 2 require the affirmative vote of a majority of the Company's outstanding shares. The meeting was adjourned to provide stockholders additional time to vote and to facilitate broader participation.

image for news Plug to Hold February 2, 2026 Investor Question-and-Answer Forum Ahead of Adjourned Special Meeting

Eli Lilly said it will spend $3.5 billion to build a manufacturing plant in Lehigh Valley, Pennsylvania, that will help make its next-generation obesity drugs. That includes a closely watched experimental drug called retatrutide, which has shown the highest weight loss of any treatment seen to date in a late-stage trial.

image for news Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

DraftKings Stock Falls As CFTC Shifts Prediction Market Policy — Negative

DKNG   Benzinga — January 30, 2026

DraftKings Inc. (NASDAQ: DKNG) shares declined on Friday. The decline comes as Guggenheim lowered its price target on the stock and the Commodity Futures Trading Commission (CFTC) announced a major policy shift regarding prediction markets.

image for news DraftKings Stock Falls As CFTC Shifts Prediction Market Policy

Verizon Surpasses Q4 Earnings Estimates on Healthy Revenue Growth — Positive

VZ   Zacks Investment Research — January 30, 2026

VZ beats Q4 estimates as broadband growth and fiber densification boost revenue despite higher expenses.

image for news Verizon Surpasses Q4 Earnings Estimates on Healthy Revenue Growth

Best Momentum Stocks to Buy for January 30th — Positive

FOR  WNEB   Zacks Investment Research — January 30, 2026

FOR and WNEB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 30th, 2026.

image for news Best Momentum Stocks to Buy for January 30th

Meta, Microsoft Earnings Signal AI Payoff Matters: ETFs in Focus — Negative

META   Zacks Investment Research — January 30, 2026

Payoff worries in the artificial intelligence (AI) space are back. Big Tech earnings sent a clear warning this week: pour money into AI, but show results soon — or pay the price.

image for news Meta, Microsoft Earnings Signal AI Payoff Matters: ETFs in Focus

GrafTech (EAF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news GrafTech International (EAF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

American Express (AXP) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive

AXP   Zacks Investment Research — January 30, 2026

Although the revenue and EPS for American Express (AXP) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news American Express (AXP) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Newell Brands (NWL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral

NWL   Zacks Investment Research — January 30, 2026

Newell Brands (NWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Newell Brands (NWL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Earnings Preview: RXO (RXO) Q4 Earnings Expected to Decline — Negative

RXO   Zacks Investment Research — January 30, 2026

RXO (RXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: RXO (RXO) Q4 Earnings Expected to Decline

Earnings Preview: Graham (GHM) Q3 Earnings Expected to Decline — Negative

GHM   Zacks Investment Research — January 30, 2026

Graham (GHM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Graham (GHM) Q3 Earnings Expected to Decline

Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for — Negative

BIIB   Zacks Investment Research — January 30, 2026

Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for

CBOE Global (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive

CBOE   Zacks Investment Research — January 30, 2026

CBOE (CBOE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news CBOE Global (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Under Armour (UAA) Expected to Beat Earnings Estimates: Should You Buy? — Positive

UAA   Zacks Investment Research — January 30, 2026

Under Armour (UAA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Under Armour (UAA) Expected to Beat Earnings Estimates: Should You Buy?